Creatv Bio partners with Neovia Oncology to study multiple drug resistance in solid tumours
FDA accepts Genentech's giredestrant application for early-stage breast cancer
Amgen receives EU marketing authorisation for IMDYLLTRA in ES-SCLC
Anixa secures Canadian patent milestone for ovarian cancer vaccine
Rallybio and Avenzo Therapeutics announce merger agreement and USD215m financing
IBA launches Cyclone iKure for industrial-scale Astatine-211 production
Avacta reports encouraging early efficacy signals for AVA6000 in salivary gland cancer at ASCO 2026
Dizal presents positive NSCLC data for DZD6008 and golidocitinib at ASCO 2026
TiumBio presents Phase 2a interim data for Tosposertib plus pembrolizumab at ASCO 2026
ImmVira reports 100% CRR at 9 months in bladder carcinoma in situ with MVR-T3011
CARsgen presents long-term satri-cel follow-up results at 2026 ASCO Annual Meeting
AstraZeneca secures US approval for Imfinzi–BCG regimen in high‑risk bladder cancer
Whitehawk Therapeutics to present at Jefferies 2026 Global Healthcare Conference
Innovent Biologics and Pfizer agree global collaboration to develop innovative oncology medicines